AU7873187A
(en)
*
|
1986-08-08 |
1988-02-24 |
University Of Minnesota |
Method of culturing leukocytes
|
AU2925789A
(en)
*
|
1987-12-17 |
1989-07-19 |
Browning's Clinical Pathology Services Limited |
Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection
|
JP2981486B2
(ja)
*
|
1988-06-14 |
1999-11-22 |
メディカル・バイオロジー・インスティチュート |
哺乳動物の免疫系研究方法
|
WO1990004412A1
(en)
*
|
1988-10-27 |
1990-05-03 |
Regents Of The University Of Minnesota |
Liposome immunoadjuvants containing il-2
|
JPH04503607A
(ja)
*
|
1989-02-24 |
1992-07-02 |
イムノセラピューティックス・インコーポレイテッド |
固定化サイトカイン類
|
GR1001034B
(el)
*
|
1989-07-21 |
1993-03-31 |
Ortho Pharma Corp |
Μεθοδος διεγερσης του πολλαπλασιασμου λεμφοκυτταρων περιφερειακου αιματος.
|
US5514392A
(en)
*
|
1989-08-30 |
1996-05-07 |
Seawell Corporation N.V. |
Packaging for perishable goods
|
JP2618497B2
(ja)
*
|
1989-10-03 |
1997-06-11 |
鐘淵化学工業株式会社 |
腫瘍障害細胞誘導剤および腫瘍障害細胞誘導デバイス
|
AU663711B2
(en)
*
|
1991-04-05 |
1995-10-19 |
Regents Of The University Of Minnesota |
Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
|
US5725855A
(en)
*
|
1991-04-05 |
1998-03-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
|
IE922233A1
(en)
*
|
1991-07-10 |
1993-01-13 |
Augusto C Ochoa |
Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
|
EP0624095B2
(en)
*
|
1991-12-31 |
2005-07-20 |
Zymogenetics, Inc. |
Methods and compositions for reducing blood loss
|
US5861158A
(en)
*
|
1993-11-17 |
1999-01-19 |
The United States Of America As Represented By The Deptartment Of Health And Human Services |
Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
|
US7067318B2
(en)
*
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
US6692964B1
(en)
*
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
CA2220226C
(en)
*
|
1995-05-04 |
2008-10-21 |
Carl H. June |
Improved methods for transfecting t cells
|
US20020182730A1
(en)
*
|
1995-07-26 |
2002-12-05 |
Micheal L. Gruenberg |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
EP0889693A1
(en)
*
|
1996-02-21 |
1999-01-13 |
Cira Technologies Inc. |
Cellular immunotherapy
|
JP4186013B2
(ja)
*
|
1996-07-15 |
2008-11-26 |
暉彬 関根 |
ウイルス感染症の治療・予防剤、その調製方法
|
EP1189635A4
(en)
*
|
1999-06-17 |
2003-04-23 |
Univ Vermont |
AUTOLOGOUS ADOPTIVE IMMUNOTHERAPY WITH T-CELLS OR B-CELLS B WHICH HAVE BEEN SENSITIZED TO ANTIGENS-SPECIFIC
|
US6406699B1
(en)
*
|
1999-10-05 |
2002-06-18 |
Gary W. Wood |
Composition and method of cancer antigen immunotherapy
|
US6797514B2
(en)
*
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
US20030235908A1
(en)
*
|
2000-02-24 |
2003-12-25 |
Xcyte Therapies, Inc. |
Activation and expansion of cells
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
US6867041B2
(en)
*
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
US7572631B2
(en)
*
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
US20030119185A1
(en)
*
|
2000-02-24 |
2003-06-26 |
Xcyte Therapies, Inc. |
Activation and expansion of cells
|
CA2377874A1
(en)
*
|
2000-05-25 |
2001-11-29 |
Xcyte Therapies, Inc. |
Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression
|
FR2821947B1
(fr)
*
|
2001-03-12 |
2003-05-16 |
Canon Kk |
Procede et dispositif de validation de parametres definissant une image
|
US20030068306A1
(en)
*
|
2001-09-14 |
2003-04-10 |
Dilber Mehmet Sirac |
Medium
|
US20030134341A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Medcell Biologics, Llc. |
Th1 cell adoptive immunotherapy
|
AU2002341717A1
(en)
*
|
2001-09-17 |
2003-04-01 |
Medcell Biologics, Llc. |
Cell therapy system
|
US20030134415A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Gruenberg Micheal L. |
Th1 cell adoptive immunotherapy
|
US7108868B2
(en)
|
2002-03-22 |
2006-09-19 |
Unigen Pharmaceuticals, Inc. |
Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
|
US7972632B2
(en)
|
2003-02-28 |
2011-07-05 |
Unigen Pharmaceuticals, Inc. |
Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
|
US20030165588A1
(en)
|
2002-03-01 |
2003-09-04 |
Unigen Pharmaceuticals, Inc. |
Identification of free-B-ring flavonoids as potent COX-2 inhibitors
|
US20030175272A1
(en)
*
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
JP4723239B2
(ja)
*
|
2002-04-30 |
2011-07-13 |
ユニジェン・インコーポレーテッド |
治療剤としての遊離−b−環フラボノイド類とフラバン類との混合物の製剤
|
US8034387B2
(en)
|
2002-04-30 |
2011-10-11 |
Unigen, Inc. |
Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
|
US20050084967A1
(en)
|
2002-06-28 |
2005-04-21 |
Xcyte Therapies, Inc. |
Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
|
WO2004003142A2
(en)
*
|
2002-06-28 |
2004-01-08 |
Xcyte Therapies, Inc. |
Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
|
US20040175373A1
(en)
*
|
2002-06-28 |
2004-09-09 |
Xcyte Therapies, Inc. |
Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
|
WO2004089392A1
(en)
|
2003-04-04 |
2004-10-21 |
Unigen Pharmaceuticals, Inc. |
Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
|
WO2004104185A1
(en)
*
|
2003-05-08 |
2004-12-02 |
Xcyte Therapies, Inc. |
Generation and isolation of antigen-specific t cells
|
BRPI0414063A
(pt)
*
|
2003-09-02 |
2006-10-24 |
Unigen Pharmaceuticals Inc |
formulação de uma mistura de flavonóides de anel b livre e flavanos para uso na prevenção e tratamento de declìnio cognitivo e danos de memória relacionados à idade
|
EP1663308A1
(en)
*
|
2003-09-22 |
2006-06-07 |
Xcyte Therapies, Inc |
Compositions and methods to accelerate hematologic recovery
|
US20060095211A1
(en)
*
|
2003-12-05 |
2006-05-04 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
System and method for modulating a cell mediated immune response
|
US20060116824A1
(en)
*
|
2004-12-01 |
2006-06-01 |
Ishikawa Muriel Y |
System and method for modulating a humoral immune response
|
US20060047434A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Ishikawa Muriel Y |
System and method related to improving an immune system
|
US20060047436A1
(en)
*
|
2004-08-25 |
2006-03-02 |
Ishikawa Muriel Y |
System and method for magnifying an immune response
|
US20060047437A1
(en)
*
|
2004-08-25 |
2006-03-02 |
Ishikawa Muriel Y |
System and method for heightening an immune response
|
US20060182742A1
(en)
*
|
2004-08-24 |
2006-08-17 |
Ishikawa Muriel Y |
System and method for magnifying a humoral immune response
|
US20060122784A1
(en)
*
|
2004-12-03 |
2006-06-08 |
Ishikawa Muriel Y |
System and method for augmenting a humoral immune response
|
US20060047433A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Ishikawa Muriel Y |
System and method related to enhancing an immune system
|
US20060047435A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Ishikawa Muriel Y |
System and method related to augmenting an immune system
|
US20060122783A1
(en)
*
|
2004-08-24 |
2006-06-08 |
Ishikawa Muriel Y |
System and method for heightening a humoral immune response
|
DK2573166T3
(da)
*
|
2004-02-26 |
2016-07-04 |
Immunovative Therapies Ltd |
Fremgangsmåder til fremstilling af T-celler til celleterapi
|
US7592431B2
(en)
*
|
2004-02-26 |
2009-09-22 |
Immunovative Therapies, Ltd. |
Biodegradable T-cell Activation device
|
PL1749090T3
(pl)
|
2004-03-01 |
2017-12-29 |
Immunovative Therapies, Ltd. |
Sposób formułowania i kompozycja do terapii komórkowej
|
US20070207492A1
(en)
*
|
2004-08-24 |
2007-09-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems to adjust a humoral immune response
|
US20070288173A1
(en)
*
|
2004-08-24 |
2007-12-13 |
Searete Llc, A Limited Liability Corporation Of The State Of Delware |
Computational methods and systems to reinforce a humoral immune response
|
US20060257395A1
(en)
*
|
2005-05-16 |
2006-11-16 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
System and method for magnifying a humoral immune response
|
US20070265787A1
(en)
*
|
2004-08-24 |
2007-11-15 |
Searete Llc,A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems for magnifying cell-mediated immune response
|
US20070196362A1
(en)
*
|
2004-08-24 |
2007-08-23 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems to bolster an immune response
|
US20070265818A1
(en)
*
|
2004-08-24 |
2007-11-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems for heightening cell-mediated immune response
|
US20070265788A1
(en)
*
|
2004-08-24 |
2007-11-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems for augmenting cell-mediated immune response
|
US20060047439A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
System and method for improving a humoral immune response
|
US20070265817A1
(en)
*
|
2004-08-24 |
2007-11-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational systems and methods relating to fortifying an immune system
|
US20070198196A1
(en)
*
|
2004-08-24 |
2007-08-23 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational systems and methods relating to ameliorating an immune system
|
US20070265819A1
(en)
*
|
2004-08-24 |
2007-11-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems for improving cell-mediated immune response
|
US7838503B2
(en)
*
|
2005-06-15 |
2010-11-23 |
Children's Medical Center Corporation |
Methods for extending the replicative lifespan of cells
|
ES2603418T3
(es)
*
|
2006-10-04 |
2017-02-27 |
Janssen Pharmaceutica Nv |
Preparación de células presentadoras de antígeno artificial inactivado y su uso en terapias celulares
|
WO2009139921A2
(en)
*
|
2008-05-16 |
2009-11-19 |
Genelux Corporation |
Microorganisms for preventing and treating neoplasms accompanying cellular therapy
|
KR20090127973A
(ko)
*
|
2008-06-10 |
2009-12-15 |
주식회사 엔케이바이오 |
자기활성화 림프구 배양 방법
|
KR20090127974A
(ko)
*
|
2008-06-10 |
2009-12-15 |
주식회사 엔케이바이오 |
자기활성화 림프구 배양용 배지 조성물
|
US8075895B2
(en)
*
|
2009-09-22 |
2011-12-13 |
Janssen Pharmaceutica N.V. |
Identification of antigenic peptides from multiple myeloma cells
|
KR102202460B1
(ko)
|
2011-05-03 |
2021-01-14 |
이뮤노베이티브 테라피스, 엘티디. |
생세포를 포함하는 생물학적 약물을 처리하기 위한 방법
|
US9233156B2
(en)
|
2011-05-03 |
2016-01-12 |
Immunovative Therapies Ltd. |
Induction of IL-12 using immunotherapy
|
WO2013177187A2
(en)
|
2012-05-22 |
2013-11-28 |
Massachusetts Institute Of Technology |
Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
|
JP2017505447A
(ja)
|
2013-12-19 |
2017-02-16 |
オペクサ セラピューティクス,インコーポレイティド |
T細胞エピトーププロファイリング方法、t細胞組成物の製造方法及び疾患の治療方法
|
WO2015157636A1
(en)
|
2014-04-10 |
2015-10-15 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy
|
US10993997B2
(en)
|
2014-12-19 |
2021-05-04 |
The Broad Institute, Inc. |
Methods for profiling the t cell repertoire
|
TWI788307B
(zh)
|
2016-10-31 |
2023-01-01 |
美商艾歐凡斯生物治療公司 |
用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
|
JP7125392B2
(ja)
|
2016-11-17 |
2022-08-24 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
レムナント腫瘍浸潤リンパ球並びにそれを調製及び使用する方法
|
JP2020503351A
(ja)
|
2017-01-06 |
2020-01-30 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
カリウムチャネルアゴニストによる腫瘍浸潤リンパ球の増殖及びその治療的使用
|
CN110809716B
(zh)
|
2017-02-12 |
2023-07-07 |
百欧恩泰美国公司 |
基于hla的方法和组合物及其用途
|
US11254913B1
(en)
|
2017-03-29 |
2022-02-22 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
JOP20190224A1
(ar)
|
2017-03-29 |
2019-09-26 |
Iovance Biotherapeutics Inc |
عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
|
MX2020004967A
(es)
*
|
2017-11-17 |
2020-08-27 |
Iovance Biotherapeutics Inc |
Expansion de linfocitos infiltrantes del tumor (til) de aspirados con aguja fina y biopsias por puncion.
|
MX2021007556A
(es)
|
2018-12-21 |
2021-09-10 |
Biontech Us Inc |
Método y sistemas de predicción de epítopos específicos de hla de clase ii y caracterización de células t cd4+.
|
US20210038684A1
(en)
|
2019-06-11 |
2021-02-11 |
Alkermes Pharma Ireland Limited |
Compositions and Methods for Cancer Immunotherapy
|
JP2022539249A
(ja)
|
2019-07-05 |
2022-09-07 |
ケース ウェスタン リザーブ ユニバーシティ |
幹細胞培養及び幹細胞治療用プライム化培地及びプライム化方法
|
US20240150711A1
(en)
|
2021-03-01 |
2024-05-09 |
Dana-Farber Cancer Institute, Inc. |
Personalized redirection and reprogramming of t cells for precise targeting of tumors
|
WO2023201369A1
(en)
|
2022-04-15 |
2023-10-19 |
Iovance Biotherapeutics, Inc. |
Til expansion processes using specific cytokine combinations and/or akti treatment
|